Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetics of antithrombotic drugs.

Current pharmaceutical design - 1 Jan 2006

Tàssies D

Abstract excerpt

Antithrombotic therapy has improved the prognosis of patients with venous or arterial thrombosis. However, there is substantial interindividual variability in the response to antithrombotic drugs. This variability is due, in part, to genetics, which may affect the efficacy and safety of drugs used in the treatment and prevention of thrombosis. Pharmacogenetics studies the genetic factors related to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fibrinolytic Agents
Share to Genetic Predisposition to Disease
Share to Hemostasis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pharmacogenetics

Share to Polymorphism, Genetic

Share to Thrombosis

Source

Identifiers

PMID: 16842189
DOI: 10.2174/138161206777698963

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetics of antithrombotic drugs.PMID 16842189Read ↗

Pharmacogenetics in Oral Antithrombotic Therapy.Semantic proximity Read ↗

Cardiovascular pharmacogenetics of anti-thrombotic agents and non-steroidal anti-inflammatory drugs.Semantic proximity Read ↗

Pharmacogenetics and oral antithrombotic drugs.Semantic proximity Read ↗

The Role of Pharmacogenetics in Antithrombotic Therapy Management: New Achievements and Barriers Yet to OvercomeSemantic proximity Read ↗

Cardiovascular Pharmacogenomics: An Update on Clinical Studies of Antithrombotic Drugs in Brazilian Patients.Semantic proximity Read ↗

Pharmacogenetics of antiplatelet therapy.Semantic proximity Read ↗

Pharmacogenomics in thrombosis.Semantic proximity Read ↗

Use of genetic data to guide therapy in arterial disease.Semantic proximity Read ↗

Pharmacogenetics of the antiplatelet effect of aspirin.Semantic proximity Read ↗

Genetic polymorphisms and atrial fibrillation: Insights into the prothrombotic state and thromboembolic risk.Semantic proximity Read ↗

Role of platelet glycoprotein polymorphisms in cardiovascular diseases.Semantic proximity Read ↗

Oral anticoagulants: Pharmacogenetics Relationship between genetic and non-genetic factors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.